295 results on '"Barbot, Mattia"'
Search Results
2. Uncommon adrenal rest tumors and massive adrenal enlargement in adult with congenital adrenal hyperplasia mimicking metastasis from pleomorphic sarcoma
3. Heat inactivation of SARS-CoV 2 enabled the measurement of salivary cortisol during COVID-19 pandemic
4. Genetica degli adenomi ACTH secernenti: mutazioni somatiche
5. Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre
6. Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
7. Relacorilant, un nuovo bloccante selettivo del recettore dei glucocorticoidi
8. Genetica degli adenomi ACTH secernenti: mutazioni germinali
9. Clinical and biochemical data for the diagnosis of endogenous hypercortisolism: the [ldquo]Cushingomic[rdquo] approach
10. Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
11. Glucocorticoid excess and COVID-19 disease
12. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study
13. Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the First Waves of COVID-19 in North-East Italy
14. A Novel TSH Receptor Gene Variant Associated with Non-Autoimmune Hyperthyrotropinemia: A Case Report
15. Hypertension in Cushing’s Syndrome
16. La transizione del paziente con sindrome adreno-genitale da difetto di 21-idrossilasi
17. Clinical presentation and management of acromegaly in elderly patients
18. Pseudohyperaldosteronism Due to Licorice: A Practice-Based Learning from a Case Series.
19. Cushing's syndrome: Overview of clinical presentation, diagnostic tools and complications
20. New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography
21. A Novel Somatostatin Receptor Ligand for Human ACTH- and GH-secreting Pituitary Adenomas
22. Ketosis-prone Diabetes presenting with Acute Esophageal Necrosis or “Black Esophagus”: An Intriguing New Clinical Association.
23. Heat inactivation of SARS-CoV 2 enabled the measurement of salivary cortisol during COVID-19 pandemic
24. Approccio al paziente con Pseudo-Cushing
25. Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis
26. Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature
27. Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients
28. The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes
29. Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients
30. Hypertension in Cushing’s Syndrome
31. Metyrapone treatment in Cushing’s syndrome: a real-life study
32. Lesioni ipofisarie nel Carney Complex
33. Tromboprofilassi nel paziente con sindrome di Cushing
34. Treatment, complications and mortality of Cushing's Disease: twenty-year report from a referral Centre
35. A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas.
36. La gestione dei carriers nella iperplasia bilaterale surrenalica ARMC5 mutata
37. Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
38. Effects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing’s disease
39. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma
40. Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series
41. Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin Disorders
42. Early recognition of aggressive pituitary adenomas: a single-centre experience
43. Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome
44. Dynamic Testing for Differential Diagnosis of ACTH-Dependent Cushing Syndrome: A Systematic Review and Meta-analysis
45. OR04-4 Loss of KDM1A in Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome and in Acromegaly With Paradoxical GH Response to Oral Glucose
46. Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus
47. Sindrome di Cushing e coagulopatie
48. Idiopathic central diabetes insipidus in a large cohort of patients; The hypopituitarism ENEA rare observational (HEROS) study
49. Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia
50. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof‐of‐concept study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.